NF2 alteration in mesothelioma

por Sekido, Yoshitaka, Sato, Tatsuhiro
Publicado 2023

NF2/Merlin Inactivation and Potential Therapeutic Targets in Mesothelioma

por Sato, Tatsuhiro, Sekido, Yoshitaka
Publicado 2018

Aberrant expression of NPPB through YAP1 and TAZ activation in mesothelioma with Hippo pathway gene alterations

por Sato, Tatsuhiro, Akao, Ken, Sato, Ayuko, Tsujimura, Tohru, Mukai, Satomi, Sekido, Yoshitaka
Publicado 2023

Three newly established immortalized mesothelial cell lines exhibit morphological phenotypes corresponding to malignant mesothelioma epithelioid, intermediate, and sarcomatoid type...

por Sato, Tatsuhiro, Nakanishi, Hayao, Akao, Ken, Okuda, Maho, Mukai, Satomi, Kiyono, Tohru, Sekido, Yoshitaka
Publicado 2021

Hyaluronic acid enhances cell migration and invasion via the YAP1/TAZ-RHAMM axis in malignant pleural mesothelioma

por Shigeeda, Wataru, Shibazaki, Masahiko, Yasuhira, Shinji, Masuda, Tomoyuki, Tanita, Tatsuo, Kaneko, Yuka, Sato, Tatsuhiro, Sekido, Yoshitaka, Maesawa, Chihaya
Publicado 2017

Oxytocin receptor is a promising therapeutic target of malignant mesothelioma

por Kodama, Yuta, Tanaka, Ichidai, Sato, Tatsuhiro, Hori, Kazumi, Gen, Soei, Morise, Masahiro, Matsubara, Daisuke, Sato, Mitsuo, Sekido, Yoshitaka, Hashimoto, Naozumi
Publicado 2021

SMG6 regulates DNA damage and cell survival in Hippo pathway kinase LATS2-inactivated malignant mesothelioma

por Suzuki, Koya, Tange, Masaki, Yamagishi, Ryota, Hanada, Hiroyuki, Mukai, Satomi, Sato, Tatsuhiro, Tanaka, Takeshi, Akashi, Tomohiro, Kadomatsu, Kenji, Maeda, Tohru, Miida, Takashi, Takeuchi, Ichiro, Murakami, Hiroshi, Sekido, Yoshitaka, Murakami-Tonami, Yuko
Publicado 2022